A registry agreement regulates a patient`s informed consent to have their study data recorded in a registry database. (c) Where cro pays investigators on behalf of the sponsor, the parties agree, in the relevant DPI, on a schedule of the amounts to be paid to the investigators. The Sponsor acknowledges and agrees that cro investigators only pays in advances or advances received from the Promoter for the services of the Investigators, and that CRO does not make payments to the Investigators until it has received sufficient funds from the Sponsor. The Sponsor acknowledges and agrees that CRO is not responsible for delays in any study or project, to the extent that such delays are due to the Proponent`s inability to make an appropriate advance payment for the services of the Investigators. Sponsor also acknowledges and agrees that payments for investigator services are pass-through payments to third parties and are separate from payments for CRO services. The Sponsor agrees not to withhold payments from the Investigator unless the Sponsor has legitimate questions about the services provided by a particular investigator or has terminated a website. The payment terms and schedule also indicate what the search is not paid for. For example, for a post-authorisation clinical trial, the sponsor may not want to make the medical device available free of charge. Or a clinical website published participant data without giving the sponsor the opportunity to verify the results. The sponsor recognizes the need to continue CRO`s services to achieve its business objectives, as it is unlikely to find an equally qualified company with the expertise and know-how developed by CRO over the past eight years. In general, the goal of a clinical study is to collect safety and efficacy data on a particular drug. (b) CRO provides the Services in accordance with recognized standards in the clinical research sector and in accordance with the terms of this Agreement, the terms of the applicable IPA (including the use of economically reasonable efforts to meet each project schedule and project budget) and in accordance with all standard working instructions agreed in writing by the parties; This section of the agreement is often overlooked by sponsors, CROs, and sites.
The purpose of this section is to explicitly indicate the description of the research project. You would like to document the overall purpose of the agreement in this section. 6. Payment. For the provision of the Services, the CRO Sponsor pays a maximum amount of $amount („Cap“). Any amount exceeding the maximum amount is subject to the prior written consent of the promoter. Payments shall be made in accordance with the financial plan annexed to Annex B and shall be included by reference. [If the currency is different from the USD, it is based on the average monthly rate of the currency, as published on www.oanda.com.] All invoices are electronic to _____ Agreements or assurances by or between the Parties, in writing or orally, which have arisen in any With respect to the subject matter of this Agreement, it has been possible to relate to the subject matter of this Agreement.
All amendments or additions to this Agreement (including handwritten amendments) are null and void, except in the case of a written deed signed by authorized representatives of both parties. (b) In addition, some countries require the local representative to compensate the sites for damage caused by the study drug or otherwise damage the primary liability of the study drug. These countries are currently Singapore, Australia, Indonesia, Korea, Taiwan, China, India, New Zealand and Mexico (if IMSS sites are used). . . .